HELP 6-K: SEC filing

Helus Pharma Inc.

Filed with the SEC on · accession 0001062993-26-006039

HELP filed a 6-K (foreign company report) with the SEC on Nov 16, 2026. Helus Pharma Inc. filed a Form 6-K with the SEC for November 2026, attaching a news release dated November 15, 2026.

Summary of the filing

Helus Pharma Inc. filed a Form 6-K with the SEC for November 2026, attaching a news release dated November 15, 2026. The filing itself contains only the cover page, signature, and exhibit index, with no substantive details of the news release disclosed in the text.

Key details

RegistrantHelus Pharma Inc.
Chief financial officerGreg Cavers

✦ Ask GOAX AI about this filing — what it means for HELP, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for HELP?

Click here

Frequently asked questions

What did HELP file with the SEC on Nov 16, 2026?

HELP filed a 6-K (SEC filing). Helus Pharma Inc. filed a Form 6-K with the SEC for November 2026, attaching a news release dated November 15, 2026. The filing itself contains only the cover page, signature, and exhibit index, with no substantive details of the news release disclosed in the text.

How do I read a 6-K?

How foreign companies listed in the US report news and events — like an 8-K for them. Look at the exhibit names: "results", "resign", "notice" tell you the topic. Many 6-Ks are routine (meeting notices); results and leadership changes matter most.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 6-K (foreign company report): How foreign companies listed in the US report news and events — like an 8-K for them.

Other HELP SEC filings

Get alerts when HELP files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days